These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 16101611

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H, Ashok PW, Flett GM, Templeton A.
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H, Piaggio G, Wojdyla D, Marions L, My Huong NT, Tang OS, Fang AH, Wu SC, Kalmar L, Mittal S, Erdenetungalag R, Horga M, Pretnar-Darovec A, Kapamadzija A, Dickson K, Anh ND, Tai NV, Tuyet HT, Peregoudov A, WHO Research Group on Post-ovulatory Methods of Fertility Regulation.
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [Abstract] [Full Text] [Related]

  • 7. Oral versus self-administered vaginal misoprostol at home before surgical termination of pregnancy: a randomised controlled trial.
    Oppegaard KS, Qvigstad E, Nesheim BI.
    BJOG; 2006 Jan; 113(1):58-64. PubMed ID: 16398773
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
    Carbonell JL, Torres MA, Reyes R, Ortega L, García-Gallego F, Sánchez C.
    Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial.
    Dickinson JE, Godfrey M, Evans SF.
    J Matern Fetal Med; 1998 Jan; 7(3):115-9. PubMed ID: 9642607
    [Abstract] [Full Text] [Related]

  • 12. Randomized comparison of dry tablet insertion versus gel form of vaginal misoprostol for second trimester pregnancy termination.
    Pongsatha S, Tongsong T.
    J Obstet Gynaecol Res; 2008 Apr; 34(2):199-203. PubMed ID: 18412782
    [Abstract] [Full Text] [Related]

  • 13. Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial.
    Caliskan E, Doger E, Cakiroglu Y, Corakci A, Yucesoy I.
    Eur J Contracept Reprod Health Care; 2009 Feb; 14(1):55-60. PubMed ID: 19241302
    [Abstract] [Full Text] [Related]

  • 14. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial.
    von Hertzen H, Piaggio G, Wojdyla D, Nguyen TM, Marions L, Okoev G, Khomassuridze A, Kereszturi A, Mittal S, Nair R, Daver R, Pretnar-Darovec A, Dickson K, Nguyen DH, Nguyen HB, Hoang TD, Peregoudov A, WHO Research Group on Post-ovulatory Methods of Fertility Regulation.
    Hum Reprod; 2009 Jan; 24(1):106-12. PubMed ID: 18794161
    [Abstract] [Full Text] [Related]

  • 15. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
    Honkanen H, Piaggio G, Hertzen H, Bártfai G, Erdenetungalag R, Gemzell-Danielsson K, Gopalan S, Horga M, Jerve F, Mittal S, Thi Nhu Ngoc N, Peregoudov A, Prasad RN, Pretnar-Darovec A, Shah RS, Song S, Tang OS, Wu SC, WHO Research Group on Post-Ovulatory Methods for Fertility Regulation.
    BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
    [Abstract] [Full Text] [Related]

  • 16. Success rate of second-trimester termination of pregnancy using misoprostol.
    Prachasilpchai N, Russameecharoen K, Borriboonhirunsarn D.
    J Med Assoc Thai; 2006 Aug; 89(8):1115-9. PubMed ID: 17048418
    [Abstract] [Full Text] [Related]

  • 17. A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks.
    Bhattacharjee N, Saha SP, Ghoshroy SC, Bhowmik S, Barui G.
    Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):165-71. PubMed ID: 18366490
    [Abstract] [Full Text] [Related]

  • 18. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
    Akoury HA, Hannah ME, Chitayat D, Thomas M, Winsor E, Ferris LE, Einarson TR, Seaward PG, Ryan G, Willan AR, Windrim R.
    Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
    [Abstract] [Full Text] [Related]

  • 19. A comparison of two regimens of misoprostol for second trimester medical termination of pregnancy: a randomized trial.
    Chaudhuri S, Banerjee PK, Mundle M, Mitra SN.
    Trop Doct; 2010 Jul; 40(3):144-8. PubMed ID: 20555044
    [Abstract] [Full Text] [Related]

  • 20. Randomised controlled study comparing oral and vaginal misoprostol for cervical priming prior to surgical termination of pregnancy.
    Ashok PW, Hamoda H, Nathani F, Flett GM, Templeton A.
    BJOG; 2003 Dec; 110(12):1057-61. PubMed ID: 14664876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.